期刊文献+

hMLH1在子宫内膜异位症中的表达与意义 被引量:1

下载PDF
导出
摘要 目的探讨错配修复基因1(hMLH1)的表达与子宫内膜异位症的关系。方法采用免疫组织化学SP法检测23例子宫内膜异位症组织和20例正常子宫内膜中hMLH1的表达。结果内异症组hMLH1蛋白表达阳性率为65%(15/23),正常内膜组hMLH1蛋白表达阳性率为95%(19/20),差异有统计学意义(P<0.05)。内异症组hMLH1基因蛋白表达阴性及弱阳性率为69%(16/23)。正常内膜组中,hMLH1蛋白表达阴性及弱阳率为35%(7/20),差异有统计学意义(P<0.05)。结论hMLH1基因的无表达或表达减弱是子宫内膜异位症发生的重要机制之一。
出处 《广东医学》 CAS CSCD 北大核心 2010年第8期990-991,共2页 Guangdong Medical Journal
基金 广东省深圳市科技计划项目(编号:200703035)
  • 相关文献

参考文献2

二级参考文献41

  • 1Morrissey C, Martinez A, Zatyka M, et al. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear ceel and papillary renal cell carcinoma. Cancer Res, 2001,61(19) :7277-7281.
  • 2Yoon JH,Dammann R, Heifer GP.Hypermethylation of the CpG island of the RASSF1A gene in overian and renal cell carcinomas. Int J Cancer,2001,94(2) :212-217
  • 3Lee MG, Kim HY, Byun DS, et al. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res, 2001,61(18) :6688-6692.
  • 4Agathanggelou A, Honorio S,Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene, 2001,20(12) :1509-1518.
  • 5Khokhlatchev A, Rabizadeh S, Xavier R, et al. Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol, 2002,12(4) :253-265.
  • 6Ortic-Vega S, Khokhlatchev A, Nedwidek M, et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Norel. Oncogene, 2002,21(9): 1381-1390.
  • 7Vos MD, Ellis CA, Bell A, et al. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem, 2000,275(46):35669-35672.
  • 8Vos MD, Ellis CA, Elam C,et al. RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J Biol Chem, 2003,278 (30): 28045-28051.
  • 9Isa T, Tomita S, N.akachi A, et al. Analysis of microsatellite instability, Kras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma. Hepatogastroenterology, 2002,49(45) :604-608.
  • 10Van Engeland M, Roemen GM, Brink M, et al. K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene, 2002,21(23): 3792-3795.

共引文献53

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部